Clinical Roundup FDA approves Tibsovo as first targeted treatment for relapsed or refractory AML July 20, 2018Vol.44 No.29
Clinical Roundup Tecentriq + pemetrexed and chemotherapy reduced the risk of disease worsening or death in lung cancer July 20, 2018Vol.44 No.29
Clinical Roundup Large disparities seen in cancer mortality rates among minority subpopulations in New York July 20, 2018Vol.44 No.29
Clinical Roundup “Hijacked” cell response to stress reveals promising drug targets for blood cancer July 20, 2018Vol.44 No.29
Clinical Roundup PD-1 inhibitors may improve immune response in early-stage NSCLC July 20, 2018Vol.44 No.29
Clinical Roundup Studies show daily aspirin use reduces ovarian cancer risk and improves survival after diagnosis July 20, 2018Vol.44 No.29
Funding Opportunities DOD Breast Cancer Research Program Breakthrough Awards July 20, 2018Vol.44 No.29
In Brief NCI, NIMHD, PCF launch $26.5M study on aggressive prostate cancer in African-American men July 20, 2018Vol.44 No.29
In Brief NCCS receives grant to develop “Return to Functional Status” outcome measure July 20, 2018Vol.44 No.29
